|
2025
|
Invention
|
Anti-dll3 antibodies and uses thereof. This disclosure provides anti-DLL3 antibodies, including m... |
|
|
Invention
|
Anti-glypican 3 antibodies.
This disclosure provides anti-GPC3 antibodies, including murine anti... |
|
2024
|
Invention
|
B7-h3 antibody-drug conjugate and use thereof. pp Formula I |
|
|
Invention
|
Anti-cdh17 antibodies and uses thereof. Antibodies having highly selective specificity to the hum... |
|
|
Invention
|
Antibody drug conjugate targeting gpc3 and use thereof. The present invention relates to a GPC3 a... |
|
|
Invention
|
5t4 antibody-drug conjugate and use thereof. The present application relates to a 5T4 antibody-dr... |
|
|
Invention
|
Tumor antigen-dependent cd40 agonists antibodies.
Provided are CD40 agonist antibodies which hav... |
|
|
Invention
|
Antibody prodrugs with constant domains.
Provided are antibody prodrugs that include an immunogl... |
|
|
Invention
|
Linker drug, and preparation method and use of antibody-drug conjugate thereof. A linker-drug con... |
|
2023
|
Invention
|
Gpc3 antibody-drug conjugate and use thereof. The present invention provides an antibody-drug con... |
|
|
Invention
|
Treatment of nasopharyngeal carcinoma by using antibody conjugate targeting egfr. The present inv... |
|
|
Invention
|
Anti-cd47 antibodies and uses thereof.
Provided are anti-CD47 antibodies and fragments thereof. ... |
|
|
Invention
|
Anti-5t4 antibodies and uses thereof.
This disclosure provides anti-5T4 antibodies, variants the... |
|
|
Invention
|
Anti-5t4 antibodies and uses thereof |
|
2022
|
Invention
|
Anti-glypican 3 antibodies.
Provided are anti-GPC3 antibodies, including murine antibodies, huma... |
|
|
Invention
|
Anti-cd3 antibodies with cross-reactivity to human and cynomolgus proteins.
The present disclosu... |
|
|
Invention
|
Single-domain 4-1bb antibodies.
Provided are single domain anti-4-1BB antibodies and polypeptide... |
|
|
Invention
|
Cd3-targeting t-cell engagers with improved therapeutic index.
Antibodies against the CD3 comple... |
|
|
Invention
|
Single-domain 4-1bb antibodies. Provided are single domain anti-4-1BB antibodies and polypeptides... |
|
2021
|
Invention
|
Anti-tigit antibodies and uses thereof. Provided are anti-TIGIT antibodies and fragments thereof.... |
|
|
Invention
|
Bifunctional molecules targeting pd-l1 and tgf-beta.
Provided are anti-PD-L1 antibodies with sup... |
|
|
Invention
|
Bifunctional molecules targeting pd-l1 and tgf-beta. Provided are anti-PD-L1 antibodies with supe... |
|
|
Invention
|
Anti-cd47 antibodies and uses thereof. Provided are anti-CD47 antibodies and fragments thereof. T... |
|
2020
|
Invention
|
Bifunctional molecules targeting pd-l1 and tgf-β. Provided are anti-PD-L1 antibodies with superio... |
